Neurobiology of Alzheimer's disease

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 14, 1996, Pages 5-8

  Peskind, Elaine R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 19; GENE ISOLATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; RISK FACTOR;

ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 21; FAMILY; HUMANS; NEUROFIBRILLARY TANGLES; TAU PROTEINS;

EID: 0030477126     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42: 1097-1105
2. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41: 479-486
3. Schneider LS, Tariot PN. Emerging drugs for Alzheimer's disease: mechanisms of action and prospects for cognitive enhancing medications. Med Clin North Am 1994;78:911-934
4. Kang J, Lemaire H-G, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325:733-736
5. Tanzi RE, Gusella JF, Watkins PC, el al. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987;235:880-884
6. Selkoe DJ. Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol 1994;4:708-716
7. Simmons LK, May PC, Tomaselli KJ, et al. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 1993; 15:373-379
8. Pike CJ, Burdick D, Walencewicz AJ, el al. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993;13:1676-1687
9. Ueda K, Fukui Y, Kageyama H. Amyloid β protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid β protein. Brain Res 1994:639:240-244
10. Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993;32: 4693-4697
11. Ninomiya H, Roch J-M, Sundsmo MP, et al. Amino acid sequence RERMS represents the active domain of amyloid β/A4 protein precursor that promotes fibroblast growth. J Cell Biol 1993; 121:879-886
12. Mattson MP, Cheng B, Culwell AR, et al. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 1993;10:243-245
13. Goate A, Chartier-Harlin M-C, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706
14. 717) mutants. Science 1994;264:1336-1340
15. 717 missense mutation affects the ratio of amyloid β protein species (Aβ1-42/43 and Aβ1-40) in familial Alzheimer's disease brain. J Biol Chem 1994;269:32721-32724
16. Schmidt ML, DiDario AG, Otvos L Jr, et al. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Exp Neurol 1994;130: 311-322
17. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin I and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease. Proc Natl Acad Sci U S A 1989;86:7611-7615
18. 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992;66:223-230
19. Potter H. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease. Prog Brain Res 1992;94: 447-458
20. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-232
21. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995;373:523-527
22. Bowen DM, Smith CB, White P, et al. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976:99:459-496
23. Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976:2:1403
24. Perry EK, Perry RH, Blessed G, et al. Necropsy evidence of central cholinergic deficits in senile dementia [letter]. Lancet 1977; 1:189
25. Arendt T, Bigl V, Arendt A, et al. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol (Berl) 1983;61:101-108
26. Nagai T, McGeer PL, Peng JH, et al. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls. Neurosci Lett 1983;36:195-199
27. Whitehouse PJ, Price DL, Struble RG, et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215: 1237-1239
28. Arendt T, Bigl V, Tennstedt A, et al. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 1985;14:1-14
29. Etienne P, Robitaille Y, Wood P, et al. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 1986;19:1279-1291
30. Nitsch RM, Slack BE, Wurtman RJ, et al. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992;258:304-307
31. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-1099
32. Lee VM-Y, Trojanowski JQ. The disordered neuronal cytoskeleton in Alzheimer's disease. Curr Opin Neurobiol 1992;2:653-656
33. 2+-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. EMBO J 1990:9:3539-3544
34. Trojanowski JQ, Schmidt ML, Otvos L Jr, et al. Vulnerability of the neuronal cytoskeleton in aging and Alzheimer's disease: widespread involvement of all three major filament systems. Annual Review of Gerontology and Geriatrics 1990;10:167-182
35. Trojanowski JQ, Schmidt ML, Shin R-W, et al. Altered tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol 1993;3:45-54
36. Trojanowski JQ, Schmidt ML, Shin R-W, et al. PHFτ (A68): from pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin Neurosci 1993;1:184-191
37. Trojanowski JQ, Lee VM-Y. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias. Ann N Y Acad Sci 1994;747:92-109
38. Trojanowski JQ, Lee VM-Y. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J 1995;9:1570-1576
39. Olson MI, Shaw C-M. Presenile dementia and Alzheimer's disease in mongolism. Brain 1969;92:147-156
40. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985;17:278-282
41. Schellenberg GD. Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci U S A 1995;92:8552-8559
42. Burdick D, Soreghan B, Kwon M, et al. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 1992;267:546-554
43. Hilbich C, Kisters-Woike B, Reed J, et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J Mol Biol 1991;218:149-163
44. Jarrett JT, Lansbury PT Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993;73:1055-1058
45. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375:754-760
46. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-973
47. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977
48. Struble RG, Polinsky RJ, Hedreen JC, et al. Hippocampal lesions in dominantly inherited Alzheimer's disease. J Neuropathol Exp Neurol 1991;50:82-94
49. Bird TD, Lampe TH, Nemens EJ, et al. Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 1988;23:25-31
50. L'Hernault SW, Arduengo PM. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol 1992;119:55-68
51. Levitan D, Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene Nature 1995; 377:351-354
52. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923
53. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet 1994;7:180-184